FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to peptides, possessing ability to induce cytotoxic T-cells, which contain amino acid sequence from SEQ ID NO: 1, 2, 3, 4, 16, 17, 30, 31, 34, 36, 37, 40, 41, 45, 49, 55, 57 and 61, as well as peptides, containing said amino acid sequences, in which 1, 2 or several amino acids are substituted and/or added. Claimed invention also relates to medications for treatment or prevention of tumours, with medications containing said peptides.
EFFECT: peptides in accordance with claimed invention can be applied as vaccines.
14 cl, 5 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FOXP3 PEPTIDE VACCINE | 2007 |
|
RU2473557C2 |
| UBE2T PEPTIDE AND VACCINES CONTAINING THE SAME | 2013 |
|
RU2663350C2 |
| TEM8 PEPTIDES AND VACCINES CONTAINING THEM | 2008 |
|
RU2498993C2 |
| TOPK PEPTIDES AND THEIR VACCINES | 2012 |
|
RU2633503C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES | 2007 |
|
RU2469044C2 |
| MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THEM | 2012 |
|
RU2612905C2 |
| HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
| NEIL3 PEPTIDES AND VACCINES INCLUDING SAME | 2010 |
|
RU2600888C2 |
| KNTC2 PEPTIDES AND VACCINES CONTAINING THE SAME | 2014 |
|
RU2671395C2 |
| PEPTIDE CANCER VACCINES EXPRESSING TUMOUR-SPECIFIC ANTIGENS | 2008 |
|
RU2464275C2 |
